The Long Run with Luke Timmerman

Ep98: Mara Aspinall on Diagnostics and COVID-19

Sep 13, 2021

01:07:30

Creator website

Highlights

AI Chapters

Episode notes

The Classic Challenges for Diagnostics

02:43

Do You Still Believe in Quantitative PCR Testing?

02:37

What's the Biggest Mess?

02:31

Introduction

4min

Streamline Your Business Processes to Insure Growth

2min

Genetics and Diagnostics - What's Your Story?

3min

Ventana - What Was Your Next Step?

3min

Cancer Diagnostics - How Did You Get Your Start?

2min

Diagnostics and Therapetics - A New Era

4min

Are Diagnostics the Next Big Thing?

2min

The Classic Challenges for Diagnostics

3min

Genetic Medicine

2min

10.

Is Testing the Enemy of the Good?

3min

11.

Is It Possible to Get Rid of This Disease?

2min

12.

Testing Is the Thing That Should Be Done

4min

13.

Answer Think - The Top 3 Barriers to Growth for Life Science Companies

3min

14.

How Much Should I Get a PCR Test?

3min

15.

Rapid Anagen Tests - How Many Manufacturers Are Available?

2min

16.

Are We Testing for Pandemics?

3min

17.

Are You Getting Back to Work With Confidence?

4min

18.

Do You Know What's Best Practice?

3min

19.

Do You Still Believe in Quantitative PCR Testing?

3min

20.

Using the Information Every Lamp Has

3min

21.

How to Get a 72 Hour Advance Cove Negative Test

1min

22.

If I Had a Magic Wand What Would I Have Done Differently?

2min

23.

Anagin Test

2min

24.

What's the Biggest Mess?

3min

25.

Diagnostics Industry

3min

Mara Aspinall of Arizona State University on diagnostics and COVID-19.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.